Presentation mock-up for Retatrutide — 20 mg. The batch, COA and final commercial packaging will be confirmed before launch.
A 20 mg configuration of the investigational peptide analogue studied in multi-receptor models.
The price is published for catalogue purposes. Any quote or sale depends on product availability, batch-document verification and buyer-eligibility checks.
Retatrutide is an investigational peptide molecule studied for combined activity at GIP, GLP-1 and glucagon receptors. Clinical and preclinical literature examines how this triple signalling profile influences energy regulation, glycaemic control and metabolic parameters.
The investigated model is that of a multi-receptor agonist. Simultaneous activation of the three pathways is examined as a profile distinct from analogues that target one or two receptors.
The compound remains investigational. Study results do not authorise an RUO material for medical use, and product identity and form must be confirmed for each batch.
This summary is informational and describes research context; it is not a medical claim or recommendation for use.
Exact storage and handling conditions must come exclusively from the verified batch data sheet and COA.
No reconstitution, dosing, injection, human-use instructions are provided.
No certificate is published for this product in the staging version. A COA will appear only if it is authentic, verified and linked to the batch offered.
Conditions depend on product classification, transport requirements and destination eligibility. See our delivery and returns page.
Scientific context for Retatrutide, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for MOTS-c, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for NAD+, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →
An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg
A mitochondrial-derived peptide used in research on energy signalling and cellular responses.
10 mg
A research coenzyme involved in redox reactions and cellular metabolism. It is classified separately from peptides.
500 mg
No. Products labelled RUO are exclusively for research and are not intended for use in humans.
Prices are visible, but sale remains blocked until each product passes legal review, its documentation is checked and buyer eligibility is confirmed.
Yes, but only when they are authentic, batch-linked and verifiable. We do not publish generic certificates or invented percentages.
Add products to the cart and complete the professional eligibility form. An enquiry does not guarantee a sale.
The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.